糖尿病前期与脑结构异常相关:马斯特里赫特研究
该基于人群的队列研究纳入2228名参与者(正常糖代谢1373例、糖尿病前期347例、2型糖尿病508例),采用口服葡萄糖耐量试验判定糖代谢状态、3T MRI评估脑结构。结果显示糖尿病前期和2型糖尿病均与腔隙性梗死、较大白质高信号及较小白质体积相关,且2型糖尿病中更明显。提示中年人群糖尿病前期已出现脑结构异常,早期干预糖代谢异常或有助于预防脑部疾病。
要点
- 糖尿病前期与腔隙性梗死、较大白质高信号及较小白质体积相关。
- 2型糖尿病上述脑结构异常较糖尿病前期进一步加重。
- 糖尿病前期与灰质体积及脑微出血无显著关联。
核心结论
- 糖尿病前期与脑结构异常相关,且在2型糖尿病中进一步恶化。
- 中年人群中糖尿病前期即已出现脑结构异常,提示早期治疗糖代谢异常可能有助于预防脑部疾病。
研究设计与样本
- 马斯特里赫特研究为基于人群的队列研究,共纳入2228名参与者(正常糖代谢1373例、糖尿病前期347例、2型糖尿病508例,2型糖尿病过采样)。
- 参与者平均年龄59.2±8.2岁,女性占48.3%;采用口服葡萄糖耐量试验判定糖代谢状态,3T MRI进行脑影像检查,结果采用多变量logistic和线性回归分析。
主要发现
- 与正常糖代谢相比,糖尿病前期和2型糖尿病与腔隙性梗死存在相关(OR分别为1.61[95%CI 0.98-2.63]和1.67[1.04-2.68],P趋势=0.027)。
- 与正常糖代谢相比,糖尿病前期和2型糖尿病与较大白质高信号相关(β分别为0.07 log10转换mL[log-mL][95%CI 0.00-0.15]和0.21 log-mL[0.14-0.28],P趋势<0.001)。
- 与正常糖代谢相比,糖尿病前期和2型糖尿病与较小白质体积相关(β分别为-4.0 mL[-7.3至-0.6]和-7.2 mL[-10.4至-4.0],P趋势<0.001)。
- 糖尿病前期与灰质体积及脑微出血的存在无显著关联。
临床怎么用
- 对中年糖尿病前期人群应关注脑结构异常风险,早期识别并管理血糖异常可能有助于预防脑部疾病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Structural brain abnormalities are key risk factors for brain diseases, such as dementia, stroke, and depression, in type 2 diabetes. It is unknown whether structural brain abnormalities already occur in prediabetes. Therefore, we investigated whether both prediabetes and type 2 diabetes are associated with lacunar infarcts (LIs), white matter hyperintensities (WMHs), cerebral microbleeds (CMBs), and brain atrophy. RESEARCH DESIGN AND METHODS: We used data from 2,228 participants (1,373 with normal glucose metabolism [NGM], 347 with prediabetes, and 508 with type 2 diabetes (oversampled); mean age 59.2 ± 8.2 years; 48.3% women) of the Maastricht Study, a population-based cohort study. Diabetes status was determined with an oral glucose tolerance test. Brain imaging was performed with 3 Tesla MRI. Results were analyzed with multivariable logistic and linear regression analyses. RESULTS: Prediabetes and type 2 diabetes were associated with the presence of LIs (odds ratio 1.61 [95% CI 0.98-2.63] and 1.67 [1.04-2.68], respectively; P trend = 0.027), larger WMH (β 0.07 log10-transformed mL [log-mL] [95% CI 0.00-0.15] and 0.21 log-mL [0.14-0.28], respectively; P trend <0.001), and smaller white matter volumes (β -4.0 mL [-7.3 to -0.6] and -7.2 mL [-10.4 to -4.0], respectively; P trend <0.001) compared with NGM. Prediabetes was not associated with gray matter volumes or the presence of CMBs. CONCLUSIONS: Prediabetes is associated with structural brain abnormalities, with further deterioration in type 2 diabetes. These results indicate that, in middle-aged populations, structural brain abnormalities already occur in prediabetes, which may suggest that the treatment of early dysglycemia may contribute to the prevention of brain diseases.
引用
- van Agtmaal MJM, Houben AJHM, de Wit V, et al. Prediabetes Is Associated With Structural Brain Abnormalities: The Maastricht Study. Diabetes Care. 2018. PMID: 30327356. doi:10.2337/dc18-1132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。